Search research articles
Contact Us
Filters
Showing results (401-410 of 416) with videos related to
Page
of 42
Sort By:
Radiation Research
|
January 23, 2003
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects
E S Gilbert, M Stovall, M Gospodarowicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2006
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005
E Van Cutsem, M Dicato, N Arber, et al.
Tumori
|
July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group
J Wils, T Sahmoud, A Sobrero, et al.
Journal of Medical Genetics
|
October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma
L J Worrillow, A G Smith, K Scott, et al.
British Journal of Cancer
|
September 24, 2004
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
N E Schoemaker, I E L M Kuppens, V Moiseyenko, et al.
ESMO Open
|
March 5, 2023
The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial
E A Dijkstra, W H Zwart, P J Nilsson, et al.
ESMO Open
|
July 7, 2022
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
P Osterlund, S Kinos, P Pfeiffer, et al.
British Journal of Cancer
|
March 11, 2018
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
N O Elander, K Aughton, P Ghaneh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
E Van Cutsem, M Dicato, N Arber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 10, 2007
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006
C Verslype, E Van Cutsem, M Dicato, et al.
Page
of 42
Search research articles
Search
Showing results (401-410 of 416) with videos related to
Sort By:
Page
of 42
Radiation Research
|
January 23, 2003
Lung cancer after treatment for Hodgkin's disease: focus on radiation effects
E S Gilbert, M Stovall, M Gospodarowicz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2006
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005
E Van Cutsem, M Dicato, N Arber, et al.
Tumori
|
July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group
J Wils, T Sahmoud, A Sobrero, et al.
Journal of Medical Genetics
|
October 26, 2007
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma
L J Worrillow, A G Smith, K Scott, et al.
British Journal of Cancer
|
September 24, 2004
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer
N E Schoemaker, I E L M Kuppens, V Moiseyenko, et al.
ESMO Open
|
March 5, 2023
The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial
E A Dijkstra, W H Zwart, P J Nilsson, et al.
ESMO Open
|
July 7, 2022
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
P Osterlund, S Kinos, P Pfeiffer, et al.
British Journal of Cancer
|
March 11, 2018
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
N O Elander, K Aughton, P Ghaneh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2010
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
E Van Cutsem, M Dicato, N Arber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 10, 2007
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006
C Verslype, E Van Cutsem, M Dicato, et al.
Page
of 42